Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib ADRs and Biomarkers in Stage IV Cancers
NCT03475589Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Rivoceranib in gastric cancer (GC), non-small cell lung cancer (NSCLC), breast cancer, ovarian cancer, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
gastric cancer (GC)non-small cell lung cancer (NSCLC)breast cancerovarian cancer
Beyond the preview
Go deeper on NCT03475589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03475589.